News & Trends - MedTech & Diagnostics
Game-changing portable CT scanner to allow rapid access to treatment
MedTech News: Innovative Adelaide-based manufacturer has received funding to develop a game-changing portable brain scanner from the Australian Government’s Medical Research Future Fund (MRFF).
The scanner will be small enough to be placed in ambulances or Royal Flying Doctor Service aircraft and will give more Australians rapid access to treatment in the crucial first “golden hour” after a stroke.
It is expected to revolutionise stroke care particularly for rural and remote Australians who are twice as likely as city stroke survivors to be left with a serious, lifelong disability.
The Australian Stroke Alliance received $40 million under the initiative for a five-year program to lay the foundations for a national and equitable approach to the treatment of stroke.
Micro-X will receive $8 million of that to develop the portable scanner using their unique technology.
Stroke patients have a much greater chance of surviving and avoiding long-term brain damage if they are diagnosed and treatment begins within that first hour.
“We are excited to be at the forefront in developing technology which has the potential to radically transform health care for all Australians,” Micro-X Managing Director Peter Rowland said.
“This unique collaboration puts Australia and the Australian Stroke Alliance at the forefront of global best practice in stroke care which may be adopted as the new standard for stroke diagnosis.”
The Frontier Health and Medical Research Initiative allows researcher collaborations to explore bold and exciting ideas that could have a dramatic, global impact on health care.
Micro-X, based in the Tonsley innovation hub in southern Adelaide, has developed world-leading, proprietary technology for miniaturising x-ray sources.
The breakthrough was made possible by the discovery of Micro-X’s patented carbon nanotube (CNT) emitter technology.
News & Trends - Pharmaceuticals
Lilly and Boehringer attract local trials to tackle obesity and its cardiovascular risks
Obesity remains a pressing public health issue, serving as a key driver of numerous complications, including atherosclerotic cardiovascular disease (ASCVD) […]
MoreNews & Trends - MedTech & Diagnostics
‘We need relief now; we can’t wait for another talkfest,’ asserts CEO of Day Hospitals Australia
The private healthcare sector is grappling with escalating tensions between private hospitals and health insurers, with no resolution in sight. […]
MoreNews & Trends - Pharmaceuticals
BeiGene’s BTK inhibitor delivers promising long-term results in newly released data
Bruton tyrosine kinase (BTK) inhibitors have improved treatment outcomes for patients with chronic lymphocytic leukaemia (CLL) and small lymphocytic lymphoma […]
MoreCommunication
Mastering the art of saying ‘No’ to protect your career and well-being: Psychologist
As the year draws to a close, professionals and leaders alike are faced with increasing pressure to meet deadlines, complete […]
More